Literature DB >> 25887082

HIV-associated memory B cell perturbations.

Zhiliang Hu1, Zhenwu Luo2, Zhuang Wan3, Hao Wu4, Wei Li4, Tong Zhang5, Wei Jiang6.   

Abstract

Memory B-cell depletion, hyperimmunoglobulinemia, and impaired vaccine responses are the hallmark of B cell perturbations inhuman immunodeficiency virus (HIV) disease. Although B cells are not the targets for HIV infection, there is evidence for B cell, especially memory B cell dysfunction in HIV disease mediated by other cells or HIV itself. This review will focus on HIV-associated phenotypic and functional alterations in memory B cells. Additionally, we will discuss the mechanism underlying these perturbations and the effect of anti-retroviral therapy (ART) on these perturbations.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-retroviral therapy; HIV; Memory B cells; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 25887082      PMCID: PMC4420662          DOI: 10.1016/j.vaccine.2015.04.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  97 in total

Review 1.  Memory B and memory plasma cells.

Authors:  Taketoshi Yoshida; Henrik Mei; Thomas Dörner; Falk Hiepe; Andreas Radbruch; Simon Fillatreau; Bimba F Hoyer
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

2.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

3.  Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis.

Authors:  H Nagase; K Agematsu; K Kitano; M Takamoto; Y Okubo; A Komiyama; K Sugane
Journal:  Clin Immunol       Date:  2001-08       Impact factor: 3.969

4.  Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection.

Authors:  Oluwadamilola H Iwajomo; Adam Finn; Peter Moons; Rose Nkhata; Enoch Sepako; Abiodun D Ogunniyi; Neil A Williams; Robert S Heyderman
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

5.  Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Authors:  Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

6.  A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.

Authors:  C-C Hung; S-Y Chang; C-T Su; Y-Y Chen; S-F Chang; C-Y Yang; W-C Liu; C-H Wu; S-C Chang
Journal:  HIV Med       Date:  2009-07-29       Impact factor: 3.180

7.  Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.

Authors:  Joseph Illingworth; Noah S Butler; Sophie Roetynck; Jedida Mwacharo; Susan K Pierce; Philip Bejon; Peter D Crompton; Kevin Marsh; Francis M Ndungu
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

8.  Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.

Authors:  Matthieu Perreau; Anne-Laure Savoye; Elisa De Crignis; Jean-Marc Corpataux; Rafael Cubas; Elias K Haddad; Laurence De Leval; Cecilia Graziosi; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2012-12-17       Impact factor: 14.307

9.  Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Authors:  Sylvie Amu; Gitit Lavy-Shahaf; Alberto Cagigi; Bo Hejdeman; Silvia Nozza; Lucia Lopalco; Ramit Mehr; Francesca Chiodi
Journal:  Retrovirology       Date:  2014-09-11       Impact factor: 4.602

10.  Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.

Authors:  Alasdair Bamford; Peter Kelleher; Hermione Lyall; Mitch Haston; Marta Zancolli; David Goldblatt; Beate Kampmann
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

View more
  15 in total

Review 1.  Extrafollicular activities: perspectives on HIV infection, germinal center-independent maturation pathways, and KSHV-mediated lymphoproliferation.

Authors:  Jennifer Totonchy
Journal:  Curr Opin Virol       Date:  2017-08-03       Impact factor: 7.090

2.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

Review 3.  Immunosenescence and hurdles in the clinical management of older HIV-patients.

Authors:  Marco Ripa; Stefania Chiappetta; Giuseppe Tambussi
Journal:  Virulence       Date:  2017-02-21       Impact factor: 5.882

4.  Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.

Authors:  Jernej Pušnik; Stephanie Fischinger; Ulf Dittmer; Stefan Esser; Marit J van Gils; Rogier W Sanders; Galit Alter; Hendrik Streeck
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

5.  Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Gordana Halec; Tim Waterboer; Nicole Brenner; Julia Butt; W David Hardy; Gypsyamber DʼSouza; Steven Wolinsky; Bernard J Macatangay; Michael Pawlita; Roger Detels; Otoniel Martínez-Maza; Shehnaz K Hussain
Journal:  J Acquir Immune Defic Syndr       Date:  2019-03-01       Impact factor: 3.771

6.  Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.

Authors:  Manuela Pogliaghi; Marco Ripa; Simone Pensieroso; Monica Tolazzi; Stefania Chiappetta; Silvia Nozza; Adriano Lazzarin; Giuseppe Tambussi; Gabriella Scarlatti
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

7.  Antiretroviral naive and treated patients: Discrepancies of B cell subsets during the natural course of human immunodeficiency virus type 1 infection.

Authors:  Olga Tsachouridou; Lemonia Skoura; Pantelis Zebekakis; Apostolia Margariti; Adamantini Georgiou; Dimitrios Bougiouklis; Dimitrios Pilalas; Antonios Galanos; Michael Daniilidis; Symeon Metallidis
Journal:  World J Virol       Date:  2016-11-12

8.  HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.

Authors:  Angeline Rouers; Jéromine Klingler; Bin Su; Assia Samri; Géraldine Laumond; Sophie Even; Véronique Avettand-Fenoel; Clemence Richetta; Nicodème Paul; Faroudy Boufassa; Laurent Hocqueloux; Hugo Mouquet; Christine Rouzioux; Olivier Lambotte; Brigitte Autran; Stéphanie Graff-Dubois; Christiane Moog; Arnaud Moris
Journal:  EBioMedicine       Date:  2017-05-31       Impact factor: 8.143

9.  Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B Cells.

Authors:  Itziar Ubillos; Joseph J Campo; Pilar Requena; Maria Ome-Kaius; Sarah Hanieh; Honor Rose; Paula Samol; Diana Barrios; Alfons Jiménez; Azucena Bardají; Ivo Mueller; Clara Menéndez; Stephen Rogerson; Gemma Moncunill; Carlota Dobaño
Journal:  Front Immunol       Date:  2017-08-21       Impact factor: 7.561

10.  Immediate access to antiretroviral therapy is important in children living with HIV.

Authors:  Sangeeta Das Bhattacharya; Bikas K Arya
Journal:  J Family Med Prim Care       Date:  2016 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.